Weekly Recap | Asymchem -3.42%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:42 AM06821-3.54%
Weekly Recap | CHINARES PHARMA -5.79%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:30 AM03320+1.59%
Weekly Recap | CF PHARMTECH -3.97%, early rally fades to lowWeekly Review·Nov 14, 2026 at 05:25 AM02652-4.34%
Weekly Recap | HUTCHMED -3.24%, most brokers rate it buyWeekly Review·Nov 14, 2026 at 05:05 AM00013-1.29%
Weekly Recap | CAM HSBIOTECH -2.95%, just above the 20-day averageWeekly Review·Nov 14, 2026 at 04:02 AM03069-2.50%
Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye GelPUBT·Nov 13, 2026 at 10:42 AM06622-3.69%
10 CN Ministries Issue Pharma Industry '15th 5Y' Plan, Targeting Revenue of No Less Than RMB3.5T by 2030AASTOCKS News·Sep 18, 2026 at 04:31 AM5120100.00%520500-3.09%
Guotai Asset Management sees China innovative drug rally as event-driven rebound after pullbackPUBT·Sep 14, 2026 at 10:16 AM159316-3.15%512290-0.40%
10:19 ETPharmaceutical CDMO Market to Reach US$ 270.3 Bn by 2031, Growing at 7.2% CAGR, New Report by Wissen Researchprnewswire·Sep 8, 2026 at 02:21 PMIXJ+0.42%IBB-0.44%
Hong Kong Innovative Drug Stocks Extend Gains as Index Rises 2.55%CoinLive·Sep 4, 2026 at 01:52 AM159992-1.36%159892-2.16%
Guotai Asset Management says China innovative drug stocks pull back after rally, sees dip-buying windowPUBT·Aug 21, 2026 at 09:23 AMBBH-0.68%LABD+1.64%
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20, 2026 at 06:00 AM513060-1.68%159859-1.38%